Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO.
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO; Pulmonary Section, Rocky Mountain Regional VA Medical Center, Aurora, CO.
Clin Lung Cancer. 2020 Nov;21(6):e640-e646. doi: 10.1016/j.cllc.2020.05.018. Epub 2020 May 23.
Lung cancer screening (LCS) implementation is complicated by the Centers for Medicare and Medicaid Services reimbursement requirements of shared decision-making and tobacco cessation counseling. LCS programs can utilize different structures to meet these requirements, but the impact of programmatic structure on provider behavior and screening outcomes is poorly described.
In a retrospective chart review of 624 patients in a hybrid structure, academic LCS program, we compared characteristics and outcomes of primary care provider (PCP)- and specialist-screened patients. We also assessed the impact of the availability of an LCS specialty clinic and best practice advisory (BPA) on PCP ordering patterns using electronic medical record generated reports.
During the study period of July 1, 2014 through June 30, 2018, 48% of patients were specialist-screened and 52% were PCP-screened; there were no clinically relevant differences in patient characteristics or screening outcomes between these populations. PCPs demonstrate distinct practice patterns when offered the choice of specialist-driven or PCP-driven screening. Increased exposure to a LCS BPA is associated with increased PCP screening orders. The addition of a nurse navigator into the LCS program increased documentation of shared decision-making and tobacco cessation counseling to > 95% and virtually eliminated screening of ineligible patients.
Systematic interventions including a BPA and nurse navigator are associated with increased screening and improved program quality, as evidenced by reduced screening of ineligible patients, increased lung cancer risk of the screened population, and improved compliance with LCS guidelines. Individual PCPs demonstrate clear preferences regarding LCS that should be considered in program design.
医疗保险和医疗补助服务中心(Centers for Medicare and Medicaid Services)对肺癌筛查(Lung cancer screening,LCS)实施的报销要求包括共同决策和戒烟咨询。LCS 项目可以采用不同的结构来满足这些要求,但项目结构对提供者行为和筛查结果的影响描述得很少。
在一个学术性 LCS 项目的混合结构中,我们对 624 名患者进行了回顾性图表审查,比较了初级保健医生(PCP)和专科医生筛查患者的特征和结果。我们还使用电子病历生成的报告评估了 LCS 专科诊所和最佳实践咨询(BPA)的可用性对 PCP 订单模式的影响。
在 2014 年 7 月 1 日至 2018 年 6 月 30 日的研究期间,48%的患者由专科医生筛查,52%的患者由 PCP 筛查;这两组患者在特征和筛查结果方面没有明显差异。当提供专科驱动或 PCP 驱动的筛查选择时,PCP 表现出明显不同的实践模式。增加接触 LCS BPA 与增加 PCP 筛查订单有关。在 LCS 项目中增加护士导航员会增加共同决策和戒烟咨询的记录,达到>95%,并几乎消除了对不合格患者的筛查。
包括 BPA 和护士导航员在内的系统干预措施与增加筛查和改善项目质量有关,证据是不合格患者的筛查减少,筛查人群的肺癌风险增加,以及对 LCS 指南的遵守得到改善。个别 PCP 对 LCS 表现出明确的偏好,这在项目设计中应予以考虑。